CME/CE LIBRARY

Throughout this section, you will find information that is helpful if you are a physician, nurse or allied health care professional.

We are working to continually engage our network, by creating information to help professionals find resources about PF and provide access to up-to-date information. Continuing medical education consists of educational activities and opportunities which serve to maintain, develop, or increase the knowledge, skills, professional performance, and relationships that a physician, nurse or allied health care professional uses to provide services for patients, the public, or the profession.

CME/CE OBJECTIVES

A905 Paradigm 500x200












Monitoring the Clues in the Diagnosis & Management of PF-ILD

1.00 AMA  PRA Category 1 Credits
Release Date: March 2, 2021
Expiration Date: March 2, 2022
Held in collaboration with Thomas Jefferson University

Learning Objectives

  • Compare PF-ILD subtypes and the pathophysiology associated with the risk of progression
  • Evaluate the risk of progression among patients with PF-ILD based on laboratory data
  • Assess evidence from recent and ongoing clinical trials for clinical implications in the management of PF-ILD
A905 Paradigm 500x200












Monitoring the Clues in the Diagnosis & Management of PF-ILD

1.00 AMA  PRA Category 1 Credits™
Release Date: March 16, 2021
Expiration Date: March 16, 2022
Held in collaboration with Northwestern University 

Learning Objectives

  • Compare PF-ILD subtypes and the pathophysiology associated with the risk of progression
  • Evaluate the risk of progression among patients with PF-ILD based on laboratory data
  • Assess evidence from recent and ongoing clinical trials for clinical implications in the management of PF-ILD
A905 Paradigm 500x200














Monitoring the Clues in the Diagnosis & Management of PF-ILD

1.00 AMA  PRA Category 1 Credits
Release Date: April 15, 2021
Expiration Date: April 15, 2022
Held in collaboration with The Cleveland Clinic Florida

Learning Objectives

  • Compare PF-ILD subtypes and the pathophysiology associated with the risk of progression
  • Evaluate the risk of progression among patients with PF-ILD based on laboratory data
  • Assess evidence from recent and ongoing clinical trials for clinical implications in the management of PF-ILD

Register here.

A905 Paradigm 500x200














 Monitoring the Clues in the Diagnosis & Management of PF-ILD

1.00 AMA  PRA Category 1 Credits™
Release Date: April 27, 2021
Expiration Date: April 27, 2022
Held in collaboration with  LaBauer Pulmonary Care at Cone Health

Learning Objectives

  • Compare PF-ILD subtypes and the pathophysiology associated with the risk of progression
  • Evaluate the risk of progression among patients with PF-ILD based on laboratory data
  • Assess evidence from recent and ongoing clinical trials for clinical implications in the management of PF-ILD

Register here.

 A902 Paradigm 400x400















TEAM IPF: Through Evaluation and Appropriate Management of Idiopathic Pulmonary Fibrosis
1.00 AMA  PRA Category 1 Credits™
Release Date: May 5, 2021
Expiration Date: May 5, 2022
Held in collaboration with  LaBauer Pulmonary Care at Cone Health

Learning Objectives
  • Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease-associated ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
  • Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
  • Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making
Register here.
 A902 Paradigm 400x400













TEAM IPF: Thorough Evaluation and Appropriate Management of Idiopathic Pulmonary Fibrosis
1.00 AMA  PRA Category 1 Credits™
Release Date: June 3, 2021
Expiration Date: June 3, 2022

Learning Objectives
  • Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease-associated ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
  • Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
  • Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making 
Register here.
 A902 Paradigm 400x400














TEAM IPF: Thorough Evaluation and Appropriate Management of Idiopathic Pulmonary Fibrosis
1.00 AMA  PRA Category 1 Credits™
Release Date: June 17, 2021
Expiration Date: June 17, 2022

Learning Objectives
  • Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease-associated ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
  • Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
  • Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making 
Register here.

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >